BSE Live
Jan 06, 16:00Prev. Close
150.65
Open Price
150.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Indo American Advance Pharmaceuitcals (in Rs. Cr.) | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.37 | -0.28 | -0.84 | -0.13 | -0.17 | |
| Diluted EPS (Rs.) | 0.37 | -0.28 | -0.84 | -0.13 | -0.17 | |
| Cash EPS (Rs.) | 0.12 | -0.13 | -0.84 | -0.02 | -0.05 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 7.74 | 7.62 | 1.52 | 2.36 | 2.49 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 7.74 | 7.62 | 1.52 | 2.36 | 2.49 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.09 | 0.12 | 0.55 | 0.64 | 0.51 | |
| PBDIT/Share (Rs.) | 0.12 | -0.13 | -0.84 | -0.02 | -0.05 | |
| PBIT/Share (Rs.) | 0.12 | -0.13 | -0.84 | -0.13 | -0.17 | |
| PBT/Share (Rs.) | 0.12 | -0.13 | -0.84 | -0.13 | -0.17 | |
| Net Profit/Share (Rs.) | 0.12 | -0.13 | -0.84 | -0.13 | -0.17 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 133.89 | -112.13 | -152.57 | -3.14 | -9.50 | |
| PBIT Margin (%) | 133.89 | -112.13 | -152.57 | -19.63 | -32.79 | |
| PBT Margin (%) | 133.89 | -112.13 | -152.57 | -19.63 | -32.79 | |
| Net Profit Margin (%) | 133.89 | -112.13 | -152.57 | -19.63 | -32.79 | |
| Return on Networth / Equity (%) | 1.56 | -1.76 | -55.52 | -5.31 | -6.72 | |
| Return on Capital Employed (%) | 1.56 | -1.76 | -48.96 | -4.89 | -6.72 | |
| Return on Assets (%) | 1.56 | -1.76 | -44.59 | -4.53 | -5.75 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 1.16 | 1.57 | 29.22 | 23.09 | 17.54 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 976.71 | 16,946.53 | 11.20 | 7.79 | 1.39 | |
| Quick Ratio (X) | 976.71 | 16,946.53 | 11.20 | 7.79 | 1.39 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 221.75 | 8.39 | 8.99 | 9.01 | 9.00 | |
| EV/Net Operating Revenue (X) | 2,155.87 | 61.48 | 43.28 | 37.50 | 46.92 | |
| EV/EBITDA (X) | 1,610.16 | -54.83 | -28.36 | -1,192.31 | -493.63 | |
| MarketCap/Net Operating Revenue (X) | 2,160.71 | 61.57 | 43.40 | 37.53 | 47.02 | |
| Retention Ratios (%) | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 25.28 | 0.97 | 15.80 | 10.16 | 9.65 | |
| Price/Net Operating Revenue | 2,173.89 | 61.67 | 43.48 | 37.56 | 47.06 | |
| Earnings Yield | 0.00 | -0.02 | -0.04 | -0.01 | -0.01 |
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth